ADVERTISEMENT
HDFC Securities: Indian Pharma Market - Chronic Therapy: A Portfolio Prescription
By 2030, cardiac and diabetes will become the top two therapies, making up 27-30% of India’s pharma market, HDFC Securities says.
29 Jul 2020, 07:23 PM IST 
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
